You have no items in your shopping cart.
On Promotion
Category
Tested Applications
Reactivity
Conjugation
Biologically Active
Featured Product
Search results for: 'recombinant'
Unconjugated
SDS-PAGE: Greater than 80% as determined by reducing SDS-PAGE.
Predicted: 61.64 KDa. Observed: 62 KDa, reducing conditions
Human
Met1-Leu316
N-GST
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 25.4 KDa. Observed: 22 KDa, reducing conditions
Human
Met1-Met204
C-6His, N-T7 tag
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 24.2 KDa. Observed: 30 KDa, reducing conditions
Human
Met1-Thr198
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
Greater than 85% as determined by reducing SDS-PAGE.
Predicted: 28.2 KDa. Observed: 27-33 KDa, reducing conditions
Human
Met1-Ala225
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.78 KDa. Observed: 15 KDa, reducing conditions
Human
Ala2-Asp135
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 15.9 KDa. Observed: 26 KDa, reducing conditions
Human
Ser411-Ser536
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE.
Predicted: 17.5 KDa. Observed: 16-23 KDa, reducing conditions
Human
Met1-Ser149
C-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 36.2 KDa. Observed: 35 KDa, reducing conditions
Human
Met1-Glu313
N-6His
50 μg, 500 μg, 1 mg, 10 μgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 28.6 KDa. Observed: 32 KDa, reducing conditions
Human
Met1-Arg227
N-6His
10 μg, 50 μg, 500 μg, 1 mgUnconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 35.4 KDa. Observed: 35 KDa, reducing conditions
Human
Met1-Arg295
N-6His
50 μg, 500 μg, 1 mg, 10 μg